Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
Br J Sports Med. 2012 Sep;46(11):796-9. doi: 10.1136/bjsports-2012-091292.
Exercise-induced asthma (EIA) and bronchial hyper-responsiveness (BHR) are frequently reported among elite athletes of outdoor endurance winter sports, particularly in cross-country and biathlon skiers. The pathogenesis of EIA is related to water loss and heat-loss through the increased respiration during exercise, leading to mediator release, airways inflammation and increased parasympathetic nervous activity in the airways, causing bronchial constriction and BHR. In the competing elite athlete this is presently considered to be due to the frequently repeated increased ventilation during training and competitions in combination with the repeated environmental exposure to cold air in outdoor winter sports. It is important that athletes at risk of asthma and BHR are monitored through regular medical control with assessment of lung function and BHR, and when BHR or asthma is diagnosed, optimal controlling treatment through anti-inflammatory treatment by inhaled steroids should be started and relieving treatment (inhaled ipratropium bromide and inhaled β2-agonists) should be used to relieve bronchial constriction if present.
运动诱发性哮喘(EIA)和支气管高反应性(BHR)在户外耐力冬季运动的精英运动员中经常被报道,特别是在越野滑雪和冬季两项滑雪运动员中。EIA 的发病机制与运动时通过增加呼吸导致的水分和热量丧失有关,导致介质释放、气道炎症和气道副交感神经活动增加,导致支气管收缩和 BHR。在竞技精英运动员中,这被认为是由于训练和比赛中频繁重复的增加通气以及在户外冬季运动中反复暴露于冷空气。重要的是,通过定期的医疗控制监测有哮喘和 BHR 风险的运动员,评估肺功能和 BHR,如果诊断出 BHR 或哮喘,应通过吸入类固醇进行抗炎治疗开始最佳控制治疗,并在存在支气管收缩时使用缓解治疗(吸入溴化异丙托品和吸入β2-激动剂)。